Compare OBK & AMPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | OBK | AMPH |
|---|---|---|
| Founded | 1912 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.2B |
| IPO Year | 2018 | 2005 |
| Metric | OBK | AMPH |
|---|---|---|
| Price | $46.23 | $21.36 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 8 |
| Target Price | ★ $45.20 | $28.38 |
| AVG Volume (30 Days) | 176.9K | ★ 415.5K |
| Earning Date | 04-22-2026 | 05-07-2026 |
| Dividend Yield | ★ 2.15% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 2.40 | 2.03 |
| Revenue | N/A | ★ $719,887,000.00 |
| Revenue This Year | $26.43 | $6.90 |
| Revenue Next Year | $5.79 | $4.64 |
| P/E Ratio | $19.26 | ★ $10.32 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $31.21 | $17.03 |
| 52 Week High | $46.64 | $31.26 |
| Indicator | OBK | AMPH |
|---|---|---|
| Relative Strength Index (RSI) | 67.05 | 50.53 |
| Support Level | $34.78 | $20.41 |
| Resistance Level | N/A | $22.90 |
| Average True Range (ATR) | 1.06 | 0.84 |
| MACD | 0.18 | 0.11 |
| Stochastic Oscillator | 83.47 | 35.58 |
Origin Bancorp Inc is a financial holding company that provides personalized, relationship banking to businesses, municipalities, and personal clients in the communities it serves. The company offers a broad range of financial services and operates more than 56 locations in Dallas/Fort Worth, East Texas, Houston, North Louisiana, Mississippi, South Alabama, and the Florida Panhandle. It also provides insurance agency products and services through its wholly owned insurance agency subsidiary. The company operates in one business segment, community banking, and is mainly engaged in attracting deposits from individuals and businesses and using these deposits and borrowed funds to originate commercial, residential mortgage, construction, and consumer loans.
Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient, or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment pharmaceutical products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.